Finance

Lists
524703:BOM
Sandu Pharmaceuticals Ltd
35,66 INR
+1,60%
(+0,56) 1D
16 ოქტ, 15:52:26 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524703...
Open
35,49 INR
High
36,39 INR
Low
35,49 INR
Mkt. cap
344,51 მლნ.
Avg. vol.
2,20 ათ.
Volume
1,24 ათ.
Dividend
2,80%
Quarterly dividend
0,25 INR
Ex-dividend date
4 სექ. 2026
P/E ratio
18,15
52-wk high
50,00 INR
52-wk low
30,00 INR
EPS
1,97 INR
No. of employees
258
Open
35,49 INR
High
36,39 INR
Low
35,49 INR
Mkt. cap
344,51 მლნ.
Avg. vol.
2,20 ათ.
Volume
1,24 ათ.
Dividend
2,80%
Quarterly dividend
0,25 INR
Ex-dividend date
4 სექ. 2026
P/E ratio
18,15
52-wk high
50,00 INR
52-wk low
30,00 INR
EPS
1,97 INR
No. of employees
258
News stories
From web sources and news partners
Law360
Law360
·
1 საათის წინ
Nasdaq Sued Over Delisting Of Social Media Co.
Yahoo Finance
Yahoo Finance
·
38 წუთის წინ
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
MarketBeat
MarketBeat
·
36 წუთის წინ
Billiontoone (NASDAQ:BLLN) CEO Sells $313,016.22 in Stock
Seeking Alpha
Seeking Alpha
·
1 საათის წინ
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
About Sandu Pharmaceuticals Ltd
CEO-
Employees258
Founded1899
Headquarters-
SectorPersonal care products
Websitesandu.in
Last report
11 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
163,89 მლნ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
176,21 მლნ.
187,61 მლნ.
168,53 მლნ.
163,89 მლნ.
Cost of goods sold
83,27 მლნ.
78,87 მლნ.
85,77 მლნ.
65,40 მლნ.
Cost of revenue
83,27 მლნ.
78,87 მლნ.
85,77 მლნ.
65,40 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,38 მლნ.
26,46 მლნ.
122,83 მლნ.
27,94 მლნ.
Operating expense
86,01 მლნ.
99,99 მლნ.
78,68 მლნ.
94,76 მლნ.
Total operating expenses
169,28 მლნ.
178,86 მლნ.
164,46 მლნ.
160,16 მლნ.
Operating income
6,93 მლნ.
8,75 მლნ.
4,08 მლნ.
3,73 მლნ.
Other non operating income
480,00 ათ.
137,00 ათ.
-837,00 ათ.
174,00 ათ.
EBT including unusual items
7,15 მლნ.
8,55 მლნ.
7,47 მლნ.
3,60 მლნ.
EBT excluding unusual items
7,15 მლნ.
8,55 მლნ.
7,47 მლნ.
3,60 მლნ.
Income tax expense
1,90 მლნ.
-1,20 მლნ.
7,04 მლნ.
1,32 მლნ.
Effective tax rate
26,63%
-14,05%
94,18%
36,70%
Other operating expenses
57,94 მლნ.
71,87 მლნ.
-45,80 მლნ.
65,18 მლნ.
Net income
5,24 მლნ.
9,75 მლნ.
435,00 ათ.
2,28 მლნ.
Net profit margin
2,98%
5,20%
0,26%
1,39%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4,44 მლნ.
-
Interest expense
-266,00 ათ.
-335,00 ათ.
-212,00 ათ.
-299,00 ათ.
Net interest expenses
-266,00 ათ.
-335,00 ათ.
4,23 მლნ.
-299,00 ათ.
Depreciation and amortization charges
1,69 მლნ.
1,66 მლნ.
1,65 მლნ.
1,64 მლნ.
EBITDA
8,66 მლნ.
9,86 მლნ.
5,18 მლნ.
5,42 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები